Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,950,119
-
Total 13F shares
-
61,231,274
-
Share change
-
-8,235,806
-
Total reported value
-
$143,890,553
-
Put/Call ratio
-
15%
-
Price per share
-
$2.35
-
Number of holders
-
108
-
Value change
-
-$17,800,337
-
Number of buys
-
48
-
Number of sells
-
53
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q1 2024
As of 31 Mar 2024,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,231,274 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, ARMISTICE CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, and 683 Capital Management, LLC.
This page lists
106
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.